Hyperalgesia
|
0.520 |
Biomarker
|
phenotype |
CTD_human |
The results of the study suggest participation of COX-1, COX-2 and iNOS, but not nNOS, in transmission of pain stimuli in STZ-induced diabetic hyperalgesia.
|
17989504 |
2008 |
Malignant neoplasm of breast
|
0.360 |
Biomarker
|
disease |
CTD_human |
Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
|
18488158 |
2008 |
Breast Carcinoma
|
0.360 |
Biomarker
|
disease |
CTD_human |
Effects of a selective cyclooxygenase-2 inhibitor, nimesulide, on the growth of ovarian carcinoma in vivo.
|
18488158 |
2008 |
Carcinoma
|
0.350 |
Biomarker
|
group |
CTD_human |
Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol.
|
12189197 |
2002 |
Gastric ulcer
|
0.340 |
Biomarker
|
disease |
CTD_human |
Improved antiulcer and anticancer properties of a trans-resveratrol analog in mice.
|
19066340 |
2009 |
Rheumatoid Arthritis
|
0.340 |
Biomarker
|
disease |
CTD_human |
Induction of cyclooxygenase-1 in cultured synovial cells isolated from rheumatoid arthritis patients.
|
15167967 |
2004 |
Gastric ulcer
|
0.340 |
Biomarker
|
disease |
CTD_human |
Role of prostaglandins generated by cyclooxygenase-1 and cyclooxygenase-2 in healing of ischemia-reperfusion-induced gastric lesions.
|
10594344 |
1999 |
Schizophrenia
|
0.330 |
Biomarker
|
disease |
PSYGENET |
We found that levels of prostaglandin-endoperoxide synthase 1 (PTGS1; aka COX-1) and prostaglandin-endoperoxide receptor 3 (PTGER3) mRNA are increased, and levels of prostaglandin-endoperoxide synthase 2 (PTGS2; aka COX-2) mRNA are decreased, in older subjects with schizophrenia (> 40years of age) compared to matched normal controls or younger subjects with schizophrenia (< 40years of age).
|
22397921 |
2012 |
Mechanical Allodynia
|
0.310 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |
Asthma, Occupational
|
0.300 |
Biomarker
|
disease |
CTD_human |
Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.
|
25721048 |
2016 |
Liver Cirrhosis, Experimental
|
0.300 |
Biomarker
|
disease |
CTD_human |
Systems level analysis and identification of pathways and networks associated with liver fibrosis.
|
25380136 |
2014 |
Corpus Luteum Cyst
|
0.300 |
Biomarker
|
disease |
CTD_human |
New insights into the pathogenesis of cystic follicles in cattle: microarray analysis of gene expression in granulosa cells.
|
21239663 |
2011 |
Ovarian Cysts
|
0.300 |
Biomarker
|
disease |
CTD_human |
New insights into the pathogenesis of cystic follicles in cattle: microarray analysis of gene expression in granulosa cells.
|
21239663 |
2011 |
Heart failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Congestive heart failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Left-Sided Heart Failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Heart Failure, Right-Sided
|
0.300 |
Biomarker
|
disease |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Myocardial Failure
|
0.300 |
Biomarker
|
disease |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Heart Decompensation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
MnSOD protects against COX1-mediated endothelial dysfunction in chronic heart failure.
|
20304815 |
2010 |
Kidney Failure, Chronic
|
0.300 |
Biomarker
|
disease |
CTD_human |
Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure.
|
19420110 |
2009 |
Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |
Hyperalgesia, Primary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |
Hyperalgesia, Secondary
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |
Tactile Allodynia
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |
Hyperalgesia, Thermal
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
|
17989504 |
2008 |